U.S. Congress - Letters to Congress: S.3187 Synthetic Drug Abuse Prevention Act of 2012
S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
The following letters were written by OpenCongress.org users and sent to their elected representatives. You can start a letter of your own by clicking the links to right.
-
S.3187 Food and Drug Administration Safety and Innovation Act
paigegreene
October 05, 2012
I am writing as your constituent in the 4th Congressional district of Tennessee. I support S.3187 - Food and Drug Administration Safety and Innovation Act, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
I support this bill because I think it is important for every U.S. citizen to have access to prescription drugs if needed. Most elderly individuals cannot afford his or her medicine which is sad because most of t... -
S.3187 Food and Drug Administration Safety and Innovation Act
McMachans13
October 01, 2012
I support S.3187 - Food and Drug Administration Safety and Innovation Act, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
50% of users on OpenCongress.org, a free, non-partisan resource, support S.3187.
As noted by Food Consumer on July 28, 2012, "Durbin's Amendment No. 2127 was piggybacked onto a bill on May 22, which was set for a vote the very next day. The bill was S 3187, the Food and Drug Administration Safet...
Vote on This Bill
-
Share This Bill
More Share via Email
